ID

31689

Beschreibung

Study of Chemoradiotherapy Combined With Cetuximab in Nasopharyngeal Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT01271439 Collaborating Parties: Zhejiang Cancer Hospital Wenzhou Medical University The First Affiliate Hospital of Guangxi Medical College Xijing Hospital Hunan Cancer Hospital Jiangxi Provincial Cancer Hospital Wuhan Union Hospital, China Wuhan University Hubei Cancer Hospital Tongji University Cancer Hospital of Shantou University Shenzhen People's Hospital First People's Hospital of Foshan

Link

https://clinicaltrials.gov/show/NCT01271439

Stichworte

Versionen (2)
  1. 16.09.18 16.09.18 -
  2. 21.09.18 21.09.18 -
Rechteinhaber

Sun Yat-sen University

Hochgeladen am

21. September 2018

DOI

Für eine Beantragung loggen Sie sich ein.

Lizenz

Creative Commons BY-NC 3.0
Modell Kommentare :

Hier können Sie das Modell kommentieren. Über die Sprechblasen an den Itemgruppen und Items können Sie diese spezifisch kommentieren.

Zurück zu Modell Kommentaren
Itemgroup Kommentare für :

Item Kommentare für :

Um Formulare herunterzuladen müssen Sie angemeldet sein. Bitte loggen Sie sich ein oder registrieren Sie sich kostenlos.

Eligibility Nasopharyngeal Carcinoma NCT01271439

Englisch

Eligibility Nasopharyngeal Carcinoma NCT01271439

1 Formulare  
Inclusion Criteria
Beschreibung

Inclusion Criteria

Alias
UMLS CUI
C1512693
histologic diagnosis of nasopharyngeal carcinoma
Beschreibung

Histological Diagnosis of nasopharyngeal carcinoma

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2931822
UMLS CUI [1,2]
C0679557
range from 18～69 years old
Beschreibung

Age group

Datentyp

boolean

Alias
UMLS CUI [1]
C0001779
t3-4，n0-2，m0 (ajcc 2009)
Beschreibung

TNM Stage

Datentyp

boolean

Alias
UMLS CUI [1]
C0441915
kps ≥ 80
Beschreibung

KPS Score

Datentyp

boolean

Alias
UMLS CUI [1]
C0206065
nonmetastatic diseases
Beschreibung

Nonmetastatic diseases

Datentyp

boolean

Alias
UMLS CUI [1]
C0445092
wbc count ≥ 4×10^9/l，hemoglobin ≥ 100g/l， platelet count ≥ 100×10^9/l
Beschreibung

WBC, hemoglobin and platelet count

Datentyp

boolean

Alias
UMLS CUI [1]
C0023508
UMLS CUI [2]
C0518015
UMLS CUI [3]
C0032181
alt or ast ＜ 1.5×uln, bilirubin ＜ 1.5×uln
Beschreibung

Alt, ast and bilirubin

Datentyp

boolean

Alias
UMLS CUI [1]
C0201836
UMLS CUI [2]
C0201899
UMLS CUI [3]
C1278039
serum creatinine ＜ 1.5×uln
Beschreibung

Creatinine

Datentyp

boolean

Alias
UMLS CUI [1]
C0201976
Exclusion Criteria
Beschreibung

Exclusion Criteria

Alias
UMLS CUI
C0680251
distan metastases
Beschreibung

Distant metastases

Datentyp

boolean

Alias
UMLS CUI [1]
C1302548
previously treated (surgery，chemotherapy, radiation therapy，egfr targeted therapy or immunotherapy)
Beschreibung

Cancer previously treated with chemotherapy, surgery, immunotherapy, radiotherapy and/or egfr targeted therapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2114510
UMLS CUI [1,2]
C0543467
UMLS CUI [2]
C1514457
UMLS CUI [3]
C1514461
UMLS CUI [4,1]
C2114510
UMLS CUI [4,2]
C1522449
UMLS CUI [5,1]
C2114510
UMLS CUI [5,2]
C1739039
UMLS CUI [5,3]
C2985566
second malignancy within 5 years
Beschreibung

Previous malignancy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0262926
UMLS CUI [1,2]
C0006826
previous therapy with an investigational agent
Beschreibung

Previous therapy with investigational agent

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2114510
UMLS CUI [1,2]
C1521826
uncontrolled seizure disorder or other serious neurologic disease
Beschreibung

Uncontrolled seizure or serious neurologic disease

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0036572
UMLS CUI [1,2]
C0205318
UMLS CUI [2,1]
C0027765
UMLS CUI [2,2]
C0205082
≥ grade ш allergic reaction to any drug including in this study
Beschreibung

Allergy to drugs in the study

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0013230
UMLS CUI [1,3]
C0205082
clinically significant cardiac or respiratory disease
Beschreibung

Cardiac or respiratory comorbidity

Datentyp

boolean

Alias
UMLS CUI [1]
C0018799
UMLS CUI [2]
C0024115
creatinine clearance < 30ml/min
Beschreibung

Creatinine clearance

Datentyp

boolean

Alias
UMLS CUI [1]
C0373595
drug or alcohol addition
Beschreibung

Substance abuse

Datentyp

boolean

Alias
UMLS CUI [1]
C0038586
do not have full capacity for civil acts
Beschreibung

Capacity for civil acts

Datentyp

boolean

Alias
UMLS CUI [1,1]
C0683673
UMLS CUI [1,2]
C0332268
severe complication, active infection
Beschreibung

Active infection or severe complication

Datentyp

boolean

Alias
UMLS CUI [1]
C0009450
UMLS CUI [2]
C3495031
concurrent immunotherapy or hormone therapy for other diseases
Beschreibung

Concomitant immunotherapy or hormone therapy

Datentyp

boolean

Alias
UMLS CUI [1,1]
C2347852
UMLS CUI [1,2]
C0021083
UMLS CUI [2,1]
C2347852
UMLS CUI [2,2]
C0279025
pregnancy or lactation
Beschreibung

Pregnancy or lactation

Datentyp

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
Zum Seitenanfang zurückkehren

Ähnliche Modelle

Eligibility Nasopharyngeal Carcinoma NCT01271439

1 Formulare
Name
Typ
Description | Question | Decode (Coded Value)
Datentyp
Alias
Item Group
C1512693 (UMLS CUI)
Histological Diagnosis of nasopharyngeal carcinoma
Item
histologic diagnosis of nasopharyngeal carcinoma
boolean
C2931822 (UMLS CUI [1,1])
C0679557 (UMLS CUI [1,2])
Age group
Item
range from 18～69 years old
boolean
C0001779 (UMLS CUI [1])
TNM Stage
Item
t3-4，n0-2，m0 (ajcc 2009)
boolean
C0441915 (UMLS CUI [1])
KPS Score
Item
kps ≥ 80
boolean
C0206065 (UMLS CUI [1])
Nonmetastatic diseases
Item
nonmetastatic diseases
boolean
C0445092 (UMLS CUI [1])
WBC, hemoglobin and platelet count
Item
wbc count ≥ 4×10^9/l，hemoglobin ≥ 100g/l， platelet count ≥ 100×10^9/l
boolean
C0023508 (UMLS CUI [1])
C0518015 (UMLS CUI [2])
C0032181 (UMLS CUI [3])
Alt, ast and bilirubin
Item
alt or ast ＜ 1.5×uln, bilirubin ＜ 1.5×uln
boolean
C0201836 (UMLS CUI [1])
C0201899 (UMLS CUI [2])
C1278039 (UMLS CUI [3])
Creatinine
Item
serum creatinine ＜ 1.5×uln
boolean
C0201976 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Distant metastases
Item
distan metastases
boolean
C1302548 (UMLS CUI [1])
Cancer previously treated with chemotherapy, surgery, immunotherapy, radiotherapy and/or egfr targeted therapy
Item
previously treated (surgery，chemotherapy, radiation therapy，egfr targeted therapy or immunotherapy)
boolean
C2114510 (UMLS CUI [1,1])
C0543467 (UMLS CUI [1,2])
C1514457 (UMLS CUI [2])
C1514461 (UMLS CUI [3])
C2114510 (UMLS CUI [4,1])
C1522449 (UMLS CUI [4,2])
C2114510 (UMLS CUI [5,1])
C1739039 (UMLS CUI [5,2])
C2985566 (UMLS CUI [5,3])
Previous malignancy
Item
second malignancy within 5 years
boolean
C0262926 (UMLS CUI [1,1])
C0006826 (UMLS CUI [1,2])
Previous therapy with investigational agent
Item
previous therapy with an investigational agent
boolean
C2114510 (UMLS CUI [1,1])
C1521826 (UMLS CUI [1,2])
Uncontrolled seizure or serious neurologic disease
Item
uncontrolled seizure disorder or other serious neurologic disease
boolean
C0036572 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
C0027765 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Allergy to drugs in the study
Item
≥ grade ш allergic reaction to any drug including in this study
boolean
C0020517 (UMLS CUI [1,1])
C0013230 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
Cardiac or respiratory comorbidity
Item
clinically significant cardiac or respiratory disease
boolean
C0018799 (UMLS CUI [1])
C0024115 (UMLS CUI [2])
Creatinine clearance
Item
creatinine clearance < 30ml/min
boolean
C0373595 (UMLS CUI [1])
Substance abuse
Item
drug or alcohol addition
boolean
C0038586 (UMLS CUI [1])
Capacity for civil acts
Item
do not have full capacity for civil acts
boolean
C0683673 (UMLS CUI [1,1])
C0332268 (UMLS CUI [1,2])
Active infection or severe complication
Item
severe complication, active infection
boolean
C0009450 (UMLS CUI [1])
C3495031 (UMLS CUI [2])
Concomitant immunotherapy or hormone therapy
Item
concurrent immunotherapy or hormone therapy for other diseases
boolean
C2347852 (UMLS CUI [1,1])
C0021083 (UMLS CUI [1,2])
C2347852 (UMLS CUI [2,1])
C0279025 (UMLS CUI [2,2])
Pregnancy or lactation
Item
pregnancy or lactation
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Zum Seitenanfang zurückkehren 

Kontakt

Benutzen Sie dieses Formular für Rückmeldungen, Fragen und Verbesserungsvorschläge.

Mit * gekennzeichnete Felder sind notwendig.

Hilfe

Benötigen Sie Hilfe bei der Suche? Um mehr Details zu erfahren und die Suche effektiver nutzen zu können schauen Sie sich doch das entsprechende Video auf unserer Tutorial Seite an.

Zum Video